Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
ClinicalTrials.gov study NCT00352027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01500083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02811679. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01549886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01491841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00992446. IPD Sharing: NO. Countries: 1. Publications: 0.
Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
ClinicalTrials.gov study NCT01119794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06026319. IPD Sharing: YES. Countries: 1. Publications: 0.
AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone
ClinicalTrials.gov study NCT00395967. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00860171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
ClinicalTrials.gov study NCT03947255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00244985. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodg
ClinicalTrials.gov study NCT01458288. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02495454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00345865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01701986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02561273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00193440. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT00577629. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006478. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.